Endometrial Cancer Outcomes at KFSYSCC

Between 2015-2019, the five-year survival rate for endometrial cancer at KFSYSCC was 88.4% vs 80.5% for other hospitals in Taiwan.

Basic Information and Stage Distribution of 708 Endometrial Cancer Patients at KFSYSCC from 1990-2019

  
    


    
    
    


    
    
        
                
                Total
                1990-1994
                1995-1999
                2000-2004
                2005-2009
                2010-2014
                2015-2019
            

        
                n
                708
                3 (0.4%)
                23 (3%)
                58 (8%)
                144 (20%)
                226 (32%)
                254 (36%)
            

                Age
            

                Mean/Median
                53/53
                54/63
                52/49
                49/49
                52/52
                54/54
                53/53
            

                Range
                25-89
                27-72
                38-74
                30-82
                25-83
                25-89
                26-82
            

                Q1-Q3
                45-59
                27-72
                47-58
                42-56
                46-58
                47-60
                45-60
            

                Stage (%)
            

                I
                454 (64%)
                1 (33%)
                7 (30%)
                31 (53%)
                72 (50%)
                163 (72%)
                180 (71%)
            

                II
                52 (7%)
                1 (33%)
                1 (4%)
                9 (16%)
                23 (16%)
                7 (3%)
                11 (4%)
            

                III
                93 (13%)
                0 (0%)
                2 (9%)
                4 (7%)
                22 (15%)
                32 (14%)
                33 (13%)
            

                IV
                64 (9%)
                0 (0%)
                1 (4%)
                4 (7%)
                15 (10%)
                22 (10%)
                22 (9%)
            

                Unknown
                45 (6%)
                1 (33%)
                12 (52%)
                10 (17%)
                12 (8%)
                2 (1%)
                8 (3%)
            

    




  

	Total	1990-1994	1995-1999	2000-2004	2005-2009	2010-2014	2015-2019
n	708	3 (0.4%)	23 (3%)	58 (8%)	144 (20%)	226 (32%)	254 (36%)
Age
Mean/Median	53/53	54/63	52/49	49/49	52/52	54/54	53/53
Range	25-89	27-72	38-74	30-82	25-83	25-89	26-82
Q1-Q3	45-59	27-72	47-58	42-56	46-58	47-60	45-60
Stage (%)
I	454 (64%)	1 (33%)	7 (30%)	31 (53%)	72 (50%)	163 (72%)	180 (71%)
II	52 (7%)	1 (33%)	1 (4%)	9 (16%)	23 (16%)	7 (3%)	11 (4%)
III	93 (13%)	0 (0%)	2 (9%)	4 (7%)	22 (15%)	32 (14%)	33 (13%)
IV	64 (9%)	0 (0%)	1 (4%)	4 (7%)	15 (10%)	22 (10%)	22 (9%)
Unknown	45 (6%)	1 (33%)	12 (52%)	10 (17%)	12 (8%)	2 (1%)	8 (3%)

Based on KFSYSCC's cancer registry data from 1990 to 2019, there were a total of 708 analytic cases of endometrial cancer. The average and median ages were 53 and 53 years old, respectively, with the youngest patient at 25 and the oldest at 89 years old; the interquartile range (Q1-Q3) spanned 45-59 years. When examined by stage, 454 patients were stage I (64%), 52 were stage II (7%), 93 were stage III (13%), and 64 were stage IV (9%). The table below presents the basic patient information and stage distribution, categorized by the year of diagnosis.

Survival curves for endometrial cancer patients stratified by year of diagnosis, showing probability of overall survival over 10 years.

Survival Curves for 708 Endometrial Cancer Patients (1990-2019), Stratified by Year of Diagnosis

From 1990 to 2019, the chart illustrates the five-year observed survival rates for 708 endometrial cancer patients at KFSYSCC, stratified by the year of diagnosis. The graph shows the five-year survival rate for endometrial cancer increased from 50% in 1990-1994 to 88% in 2015-2019, while the ten-year survival rate rose from 50% in 1990-1994 to 82% in 2010-2014.

Treatment Methods and Stages for 254 Endometrial Cancer Patients at KFSYSCC (2015-2019)

  
    


    
    
    


    
    
        
            Treatment Type
            Total
            Stage I
            Stage II
            Stage III
            Stage IV
            Unknown
        

            Total
            254
            180
            11
            33
            22
            8
        

            Surgical Treatment
            244 (96%)
            177 (98%)
            11 (100%)
            33 (100%)
            15 (68%)
            8 (100%)
        

            Radiation Therapy
            77 (30%)
            37 (21%)
            9 (82%)
            26 (79%)
            5 (23%)
            0 (0%)
        

            Chemotherapy
            60 (24%)
            12 (7%)
            1 (9%)
            28 (85%)
            19 (86%)
            0 (0%)
        

            Targeted Therapy
            2 (1%)
            0 (0%)
            0 (0%)
            0 (0%)
            2 (9%)
            0 (0%)
        

            Hormone Therapy
            10 (4%)
            7 (4%)
            0 (0%)
            0 (0%)
            0 (0%)
            3 (38%)
        

            Immunotherapy
            2 (1%)
            0 (0%)
            0 (0%)
            0 (0%)
            2 (9%)
            0 (0%)
        

            Palliative Care
            6 (2%)
            0 (0%)
            0 (0%)
            0 (0%)
            6 (27%)
            0 (0%)
        

            No Record of Initial Treatment Reported
            0 (0%)
            0 (0%)
            0 (0%)
            0 (0%)
            0 (0%)
            0 (0%)
        





  

Treatment Type	Total	Stage I	Stage II	Stage III	Stage IV	Unknown
Total	254	180	11	33	22	8
Surgical Treatment	244 (96%)	177 (98%)	11 (100%)	33 (100%)	15 (68%)	8 (100%)
Radiation Therapy	77 (30%)	37 (21%)	9 (82%)	26 (79%)	5 (23%)	0 (0%)
Chemotherapy	60 (24%)	12 (7%)	1 (9%)	28 (85%)	19 (86%)	0 (0%)
Targeted Therapy	2 (1%)	0 (0%)	0 (0%)	0 (0%)	2 (9%)	0 (0%)
Hormone Therapy	10 (4%)	7 (4%)	0 (0%)	0 (0%)	0 (0%)	3 (38%)
Immunotherapy	2 (1%)	0 (0%)	0 (0%)	0 (0%)	2 (9%)	0 (0%)
Palliative Care	6 (2%)	0 (0%)	0 (0%)	0 (0%)	6 (27%)	0 (0%)
No Record of Initial Treatment Reported	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)

Between 2015 and 2019, there were a total of 254 analytic endometrial cancer cases, including 180 patients in stage I, 11 in stage II, 33 in stage III, and 22 in stage IV. In terms of treatment methods, 244 patients (96%) underwent surgical treatment, 77 (30%) received radiation therapy, 60 (24%) underwent chemotherapy, 2 (1%) received targeted therapy, 10 (4%) underwent hormone therapy, 2 (1%) received immunotherapy, and 6 (2%) received palliative care.

Survival rate graph showing five-year overall survival rates of endometrial cancer patients based on cancer stage, with stages I through IV and unknown, over five years after diagnosis.

Five-Year Survival Rates of 254 Endometrial Cancer Patients by Stage (2015-2019)

KFSYSCC’s 2015-2019 five-year observed survival rates for 254 endometrial cancer patients, stratified by stage, are presented in the following chart. As shown in the graph, the five-year survival rate is 98% for stage 1, 90% for stage 2, 76% for stage 3, and 35% for stage 4.